Sonnet BioTherapeutics Holdings, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Sonnet BioTherapeutics Holdings, Inc. (SONN) is 3.50

According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.50. This represents a change of 101.77% compared to the average of 1.74 of the last 4 quarters.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Historical Current Ratio (quarterly & annually)

How has SONN Current Ratio performed in the past?

The mean historical Current Ratio of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is 1.20. The current 3.50 Current Ratio has changed 29.11% with respect to the historical average. Over the past ten years (40 quarters), SONN's Current Ratio was at its highest in in the December 2021 quarter at 4.74. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Average Current Ratio

How has SONN Current Ratio performed in the past?

The current Current Ratio of Sonnet BioTherapeutics Holdings, Inc. (SONN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sonnet BioTherapeutics Holdings, Inc. (SONN) Current Ratio vs. Peers

How is SONN’s Current Ratio compared to its peers?

Sonnet BioTherapeutics Holdings, Inc.’s Current Ratio is less than Rallybio Corporation (12.92), less than TAO Synergies Inc. (27.40), less than Klotho Neurosciences, Inc. (95.01), greater than Exicure, Inc. (0.79), less than Intensity Therapeutics, Inc. (4.86), greater than Iterum Therapeutics plc (2.13), less than Boundless Bio, Inc. (9.87), less than Q32 Bio Inc. (5.36), greater than Cadrenal Therapeutics, Inc. Common Stock (2.68), less than iBio, Inc. (11.88),

Build a custom stock screener for Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.